07737251 is referenced by 3 patents and cites 106 patents.

This invention relates to glucagon-like peptide 2 (GLP-2) derivatives. In particular, this invention relates to GLP-2 peptide derivatives having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders or diseases such as inflammatory bowel disease and other gastrointestinal functions, from any segment of the gastrointestinal tract, from the oesophagus to the anus.

Title
Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
Application Number
11/318323
Publication Number
7737251 (B2)
Application Date
December 23, 2005
Publication Date
June 15, 2010
Inventor
Julie Carette
Ste-Catherine
CA
Karen Thibaudeau
Montreal
CA
Martin Robitaille
Granby
CA
Roger Leger
Saint-Lambert
CA
Nissab Boudjellab
Columbus
OH, US
Dominique P Bridon
San Francisco
CA, US
Agent
Jones Day
Assignee
ConjuChem Biotechnologies
CA
IPC
A61K 61/00
A61K 38/00
A61K 28/28
A61K 38/26
View Original Source